ISMRC 2023 Final Programme

PS-06-019 Gene methylation and levels of circulat- ing tumor DNA as diagnostic/prognostic biomarkers in Pancreatic Cancer biosig- natures built via automated Machine Learning Ekaterini Alexiou Chatzaki, Greece PS-06-020 Classification of brain tumors by Nanopore sequencing of cell-free DNA from cerebrospinal fluid Ann-Kristin Afflerbach, Germany PS-06-021 OUTLIVE-CRC: Improvement of prog- nosis of young colorectal cancer pa- tients through multimarker models and nutritional medical intervention – focus on liquid biopsy-based ctDNA genomics Eva Dazert-Klebsattel, Germany PS-06-022 Extracellular vesicle (EV) associated DNA: potential liquid biopsy biomarker and functional communicators in cancer Basant Kumar Thakur, Germany IDYLLA™ LIQUID BIOPSY In-house biomarker test results within 3 hours Melanoma, colorectal and lung cancers Detection of BRAF, KRAS, NRAS & EGFR mutations* Directly from 1-2 ml plasma sample Like to know more? info@biocartis.com www.biocartis.com MEET IDYLLA™ @ BOOTH #17 Sample-to-result within 3 hours *Idylla™ctBRAF ,ctKRAS,ctNRAS-BRAF-EGFRS492RandctEGFRMutationAssaysare forResearchUseOnly. Not foruse indiagnosticprocedures.©March2023,BiocartisNV.All rights reserved. Unsurpassed ease of use Suitable for any laboratory setting THINK IDYLLA™ B ECAUSE TIME MATTERS Wednesday, 3 May 2023 – Poster Sessions